DOMAIN PARTERS VII L P

10% owner at Orexigen Therapeutics, Inc. · on record since Dec 11, 2008
10% owner at CADENCE PHARMACEUTICALS INC · on record since Feb 20, 2009
10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
10% owner at TANDEM DIABETES CARE INC · on record since Nov 19, 2013
10% owner at ZOGENIX, INC. · on record since Nov 22, 2010
10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
10% owner at Evoke Pharma Inc · on record since Sep 30, 2013
10% owner at Achaogen, Inc. · on record since Mar 17, 2014
10% owner at Vyome Holdings, Inc · on record since Oct 14, 2016
10% owner at Evofem Biosciences, Inc. · on record since Nov 26, 2014
10% owner at Tobira Therapeutics, Inc. · on record since May 6, 2015

Insider trading activity of DOMAIN PARTERS VII L P

Transactions on record: 74; since Dec 11, 2008

Open-market buys: 20; $48.8M

Open-market sells: 18; $11.4M

Companies traded: 9; last filing Aug 8, 2019

Figures computed from official regulatory filings — .

Companies where DOMAIN PARTERS VII L P has traded

Vyome Holdings, Inc2 tx · $1.8M · Aug 8, 2019
Evoke Pharma Inc6 tx · $388.4K · Apr 13, 2016
CADENCE PHARMACEUTICALS INC17 tx · $63.8M · Mar 21, 2014
Achaogen, Inc.4 tx · Mar 17, 2014
6 tx · Nov 19, 2013
5 tx · $3.9M · Jul 2, 2013
10 tx · $22.2M · Jun 5, 2013
16 tx · $22.5M · Dec 22, 2011
8 tx · $16.1M · Sep 20, 2011

Track record of DOMAIN PARTERS VII L P

Statistical track record

Free account

Open-market buys: 22

Last buy: Aug 6, 2019

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of DOMAIN PARTERS VII L P

Co-insiders of DOMAIN PARTERS VII L P

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Vyome Holdings, IncListing unverified	Aug 8, 2019	BuyD (derivative)	187,500	4.00 USD	$750K	ClusterFirst in 12mo	SEC
Vyome Holdings, IncListing unverified	Aug 8, 2019	Buy	250,000	4.00 USD	$1M	conv 50ClusterFirst in 12mo	SEC
Evoke Pharma IncListing unverified	Apr 13, 2016	Sell	-4,348	5.22 USD	$22.7K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-9,832	7.78 USD	$76.5K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-32,411	7.07 USD	$229.1K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-7,920	7.58 USD	$60K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-2,972,678	14.00 USD	$41.6M	Unusual size	SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-926,321	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	Other	1,987,049	—	n/a (No price was disclosed in the filing)		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-625,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-435,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	ExerciseD (derivative)	-1,367,020	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	Exercise	1,367,020	7.84 USD	$10.7M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	Other	-765,532	14.00 USD	$10.7M		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-549,833	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	352,351	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	Other	3,189,058	—	n/a (No price was disclosed in the filing)		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-2,283,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-356,111	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-590,403	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evoke Pharma IncListing unverified	Sep 30, 2013	OtherD (derivative)	-1,114,327	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evoke Pharma IncListing unverified	Sep 30, 2013	Other	1,114,327	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	OtherD (derivative)	70,042	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	OtherD (derivative)	-489,320	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	Buy	280,923	14.00 USD	$3.9M	conv 40ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Vyome Holdings, IncListing unverified	Aug 8, 2019	BuyD (derivative)	187,500	4.00 USD	$750K	ClusterFirst in 12mo	SEC
Vyome Holdings, IncListing unverified	Aug 8, 2019	Buy	250,000	4.00 USD	$1M	conv 50ClusterFirst in 12mo	SEC
Evoke Pharma IncListing unverified	Apr 13, 2016	Sell	-4,348	5.22 USD	$22.7K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-9,832	7.78 USD	$76.5K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-32,411	7.07 USD	$229.1K		SEC
Evoke Pharma IncListing unverified	Apr 16, 2015	Sell	-7,920	7.58 USD	$60K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-2,972,678	14.00 USD	$41.6M	Unusual size	SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-926,321	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	Other	1,987,049	—	n/a (No price was disclosed in the filing)		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-625,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Achaogen, Inc.Listing unverified	Mar 17, 2014	OtherD (derivative)	-435,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	ExerciseD (derivative)	-1,367,020	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	Exercise	1,367,020	7.84 USD	$10.7M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 14, 2014	Other	-765,532	14.00 USD	$10.7M		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-549,833	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	352,351	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	Other	3,189,058	—	n/a (No price was disclosed in the filing)		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-2,283,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-356,111	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TANDEM DIABETES CARE INCListing on record	Nov 19, 2013	OtherD (derivative)	-590,403	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evoke Pharma IncListing unverified	Sep 30, 2013	OtherD (derivative)	-1,114,327	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Evoke Pharma IncListing unverified	Sep 30, 2013	Other	1,114,327	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	OtherD (derivative)	70,042	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	OtherD (derivative)	-489,320	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2013	Buy	280,923	14.00 USD	$3.9M	conv 40ClusterFirst in 12mo	SEC